CoChat

Approach to the Patient With Thyroid Nodules: Considering GLP-1 Receptor Agonists

Kelly, Clare A, Sipos, Jennifer A · 2025 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 76 of the 79 references it cites were found in a registry or an index.

Abstract

Glucagon-like peptide 1 receptor agonists (GLP1RAs) have rapidly changed the landscape of diabetes and obesity treatment. Enthusiasm for their use is tempered with concerns regarding their risk for inducing C-cell tumors based on preclinical studies in rodents. A black-box warning from the US Food and Drug Administration recommends against using GLP1RA in patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2A or 2B (MEN2), providing clear guidance regarding this cohort of patients. However, emerging data also suggest an increased incidence of differentiated thyroid cancer (DTC) in patients treated with these agents. Other studies, though, have not confirmed an association between GLP1RAs and DTC. With conflicting results concerning thyroid cancer risk, there is no clear consensus regarding the optimal approach to screening patients prior to initiating the medications and/or evaluating for thyroid cancer during GLP1RA treatment. Within the context of patient cases, this review will summarize the existing data, describe ongoing controversies, and outline future areas for research regarding thyroid cancer risk with GLP1RA use.

Overview

Integrity signals

Registry

Crossref · 10.1210/clinem/dgae722

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 76 references

Cited by

See all 30

Metadata

Authors
Kelly, C. A., & Sipos, J. A.
Affiliations
  • University Hospitals of Cleveland (US)
  • The Ohio State University Wexner Medical Center (US)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2024-10-14
Volume
110
Issue
6
Pages
e2080-e2087
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W4403398649
Cited by
30
References
79
Citations by year
2026: 20 · 2025: 10
FWCI
1.75
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
Keywords
GLP-1 receptor agonists, thyroid nodules, medullary thyroid carcinoma, multiple endocrine neoplasia type 2, differentiated thyroid cancer, thyroid cancer risk, black box warning, thyroid cancer screening, obesity treatment, diabetes treatment
MeSH terms
Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor Agonists, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Thyroid Neoplasms, Thyroid Nodule, Carcinoma, Neuroendocrine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Approach to the Patient With Thyroid Nodules: Considering GLP-1 Receptor Agonists. https://app.cochat.ai/papers/10.1210/clinem/dgae722
The paper
Kelly, C. A., & Sipos, J. A. (2025). Approach to the Patient With Thyroid Nodules: Considering GLP-1 Receptor Agonists. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae722

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.